BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21092535)

  • 21. 6-Thioguanine-related chronic hepatotoxicity and variceal haemorrhage in children treated for acute lymphoblastic leukaemia--a dual-centre experience.
    Ravikumara M; Hill FG; Wilson DC; Gillett PM; Thomas A; Brown R; Darbyshire PJ; McKiernan PJ
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):535-8. PubMed ID: 16707977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics and outcomes of patients with hepatic veno-occlusive disease induced by Gynura segetum: A retrospective study.
    Feng MX; Shen Y; Lu YQ
    J Integr Med; 2020 Sep; 18(5):434-440. PubMed ID: 32773246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reliable experimental model of hepatic veno-occlusive disease caused by monocrotaline.
    Chen MY; Cai JT; Du Q; Wang LJ; Chen JM; Shao LM
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):395-400. PubMed ID: 18693175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic veno-occlusive disease during chemotherapy for nephroblastoma: successful and safe treatment with defibrotide. Report of a clinical case.
    Cecinati V; Giordano P; De Leonardis F; Grassi M; Arcamone G; De Mattia D; Santoro N
    Immunopharmacol Immunotoxicol; 2009; 31(4):702-5. PubMed ID: 19874245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.
    Corbacioglu S; Cesaro S; Faraci M; Valteau-Couanet D; Gruhn B; Rovelli A; Boelens JJ; Hewitt A; Schrum J; Schulz AS; Müller I; Stein J; Wynn R; Greil J; Sykora KW; Matthes-Martin S; Führer M; O'Meara A; Toporski J; Sedlacek P; Schlegel PG; Ehlert K; Fasth A; Winiarski J; Arvidson J; Mauz-Körholz C; Ozsahin H; Schrauder A; Bader P; Massaro J; D'Agostino R; Hoyle M; Iacobelli M; Debatin KM; Peters C; Dini G
    Lancet; 2012 Apr; 379(9823):1301-9. PubMed ID: 22364685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia.
    Stanulla M; Schaeffeler E; Möricke A; Buchmann S; Zimmermann M; Igel S; Schmiegelow K; Flotho C; Hartmann H; Illsinger S; Sauerbrey A; Junk SV; Schütte P; Hinze L; Lauten M; Modlich S; Kolb R; Rossig C; Schwabe G; Gnekow AK; Fleischhack G; Schlegel PG; Schünemann HJ; Kratz CP; Cario G; Schrappe M; Schwab M
    Leukemia; 2021 Sep; 35(9):2650-2657. PubMed ID: 33714975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children.
    Méresse V; Hartmann O; Vassal G; Benhamou E; Valteau-Couanet D; Brugieres L; Lemerle J
    Bone Marrow Transplant; 1992 Aug; 10(2):135-41. PubMed ID: 1525602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computed tomography findings of hepatic veno-occlusive disease caused by Sedum aizoon with histopathological correlation.
    Shao H; Chen HZ; Zhu JS; Ruan B; Zhang ZQ; Lin X; Gan MF
    Braz J Med Biol Res; 2015 Dec; 48(12):1145-50. PubMed ID: 26517336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment-related sinusoidal obstruction syndrome in children with de novo acute lymphoblastic leukemia during intensification.
    McAtee CL; Schneller N; Brackett J; Bernhardt MB; Schafer ES
    Cancer Chemother Pharmacol; 2017 Dec; 80(6):1261-1264. PubMed ID: 29051993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic veno-occlusive disease related to Gynura segetum: A case report.
    Sun Z; Kang J; Zhang Y
    Medicine (Baltimore); 2018 Apr; 97(17):e0552. PubMed ID: 29703039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia.
    De Bruyne R; Portmann B; Samyn M; Bansal S; Knisely A; Mieli-Vergani G; Dhawan A
    J Hepatol; 2006 Feb; 44(2):407-10. PubMed ID: 16226335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the effects of preconditioning regimens on hepatic veno-occlusive disease in mice after hematopoietic stem cell transplantation.
    Qiao J; Fu J; Fang T; Huang Y; Mi H; Yang N; Chen C; Xu K; Zeng L
    Exp Mol Pathol; 2015 Feb; 98(1):73-8. PubMed ID: 25533545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose methylprednisolone treatment of hepatic veno-occlusive disease in a child with Wilms tumor.
    Akyüz C; CaClar K; Emir S; Büyükpamukçu M
    Pediatr Hematol Oncol; 2003 Jun; 20(4):345-9. PubMed ID: 12746168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
    Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
    Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia.
    Rozman C; Carreras E; Qian C; Gale RP; Bortin MM; Rowlings PA; Ash RC; Champlin RE; Henslee-Downey PJ; Herzig RH; Hinterberger W; Klein JP; Prentice HG; Reiffers J; Zwaan FE; Horowitz MM
    Bone Marrow Transplant; 1996 Jan; 17(1):75-80. PubMed ID: 8673059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The hemochromatosis C282Y allele: a risk factor for hepatic veno-occlusive disease after hematopoietic stem cell transplantation.
    Kallianpur AR; Hall LD; Yadav M; Byrne DW; Speroff T; Dittus RS; Haines JL; Christman BW; Summar ML
    Bone Marrow Transplant; 2005 Jun; 35(12):1155-64. PubMed ID: 15834437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic disposition and clinical outcomes in infants and children receiving intravenous busulfan for allogeneic hematopoietic stem cell transplantation.
    Schechter T; Finkelstein Y; Doyle J; Verjee Z; Moretti M; Koren G; Dupuis LL
    Biol Blood Marrow Transplant; 2007 Mar; 13(3):307-14. PubMed ID: 17317584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of hepatic vein occlusive disease after liver transplantation: A case report with literature review.
    Hou Y; Tam NL; Xue Z; Zhang X; Liao B; Yang J; Fu S; Ma Y; Wu L; He X
    Medicine (Baltimore); 2018 Jun; 97(24):e11076. PubMed ID: 29901618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical characteristics of hepatic sinusoidal obstruction syndrome: analysis of 8 cases].
    Chen HT; Xu GQ; Li YM; Liu YS; Yu CH; Zhong BS; Zheng ZL; Jiang TA; Chen CX; Gu ZY; Ren GP
    Zhonghua Nei Ke Za Zhi; 2006 Sep; 45(9):734-7. PubMed ID: 17166447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.